In addition, when the Src pathway is activated in cancer cells, the TKs5 substrate is upregulated leading to degradation of the ECM and inducing invadopodia formation; this relationship has been ratified in prostate cancer [13]. The gene discussed is SH3PXD2A; the disease is Familial prostate cancer.